Učitavanje...
A new lead to NLRP3 inhibition
The discovery of a small molecule inhibitor that targets the inflammasome sensor NLRP3 offers a new path for the development of selective inflammasome blockers with potential therapeutic benefit in a wide range of human diseases (in this issue, see Jiang et al., https://doi.org/10.1084/jem.20171419)...
Spremljeno u:
| Izdano u: | J Exp Med |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Rockefeller University Press
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5678032/ https://ncbi.nlm.nih.gov/pubmed/29061692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20171848 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|